1 Background: Obesity associated with high risk of cardiovascular disease and diabetes due to impairment in glucose and lipid metabolism as well as low grade inflammatory response. Hypothalamic hypodopaminergic state is observed in obese subject. Accordingly, treatment with Bromocriptine, a centrally acting dopamine D2-receptor agonist, was reported to regulate food intake and improve insulin sensitive … Continue reading DR.Fadhil A. Rizij